๋ฉํ๋ฆฌ๋
๋ฉํ๋ฆฌ๋(ํํฐ๋์ผ๋ก๋ ์๋ ค์ง)์ ์ฃผ๋ก ์งํต ๋ชฉ์ ์ผ๋ก ์ฌ์ฉ๋๋ ํฉ์ฑ **์คํผ์ค์ด๋ ์์ฉ์ **์ ๋๋ค. **์์ ์์ :** * ๊ณผ๊ฑฐ์๋ ๋๋ฆฌ ์ฌ์ฉ๋์์ผ๋, ์์ฉ ์๊ฐ์ด ๋งค์ฐ ์งง๊ณ (๊ฐ์ ๊ณ ์์ด์์ 1~2์๊ฐ ๋ฏธ๋ง) ํนํ ์ ๋งฅ ํฌ์ฌ ์ **ํ์คํ๋ฏผ ๋ฐฉ์ถ** ๋ฐ ์ ํ์์ ์ ๋ฐํ ๊ฐ๋ฅ์ฑ์ด ๋์ ํ๋ ์์ํ์์๋ ์ฌ์ฉ์ด ํฌ๊ฒ ๊ฐ์ํ์ต๋๋ค. * ๋๋ถ๋ถ์ ๋ค๋ฅธ ์คํผ์ค์ด๋์ ๋ฌ๋ฆฌ ๋ฉํ๋ฆฌ๋์ **ํญ์ฝ๋ฆฐ์ฑ(๋ฏธ์ฃผ์ ๊ฒฝ ์ฐจ๋จ) ๋ฐ ์์ฑ ๋ณ๋ ฅ ์์ฉ**์ ๊ฐ์ง๊ณ ์์ด, ์์ ๋ฎค(mu) ์์ฉ์ ์์ ํํ ๋ณผ ์ ์๋ ์๋งฅ ๋์ ๋น๋งฅ์ ์ ๋ฐํ ์ ์์ต๋๋ค. * ํจ๋ฅ์ ๋ชจ๋ฅดํ์ ์ฝ 1/3์์ 1/8 ์์ค์ด์ง๋ง, ๋์ผํ ์งํต ํจ๊ณผ๋ฅผ ๋ด๋ ์ฉ๋์์๋ ๋๋ฑํ ํธํก ์ต์ ๋ฅผ ์ ๋ฐํฉ๋๋ค. * ์ด ์ฝ๋ฌผ์ C-II ํต์ ๋ฌผ์ง(๋ง์ฝ๋ฅ)์ ๋๋ค.
์์ฉ ๊ธฐ์ : Meperidine acts primarily as an agonist at the **mu (ฮผ) opioid receptors** in the central nervous system (CNS) and peripheral tissues. * **Receptor Binding:** Binds to G-protein coupled mu receptors โ inhibits adenylate cyclase โ decreases intracellular cAMP. * **Ion Channel Modulation:** Promotes opening of potassium channels (causing hyperpolarization) and inhibits voltage-gated calcium channels (decreasing neurotransmitter release). * **Analgesia:** Inhibits ascending nociceptive pathways and alters the perception of pain. * **Unique Mechanisms:** Exhibits **anticholinergic (vagolytic)** effects and can cause direct mast cell degranulation leading to **histamine release**.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Perioperative pain ยท 3-5 mg/kg ยท IM, SC ยท 1-2 hours
- Analgesia ยท 2-5 mg/kg ยท IM, SC ยท short (30 minutes to an hour)
- Pre-medication ยท 3-4 mg/kg ยท IM ยท In healthy cats
- Post-op analgesia ยท 1-2 mg/kg ยท IM ยท In healthy cats
- General Note ยท Not recommended for cats
- Analgesia (mild to moderate pain) ยท 5-10 mg/kg ยท IM, SC ยท q1-2h ยท Depending on pain assessment ยท Frequent redosing is required.
- Restraining agent (preanesthetic) ยท 1-2 mg/kg ยท IM ยท 45-60 minutes before anesthesia ยท Used in combination with promazine (2 mg/kg IM) and atropine (0.07-0.09 mg/kg IM) in separate sites.
- Analgesia ยท 2 mg/kg ยท IM ยท q4h ยท as needed
- Analgesia ยท 5-10 mg/kg ยท SC, IM ยท q2-3h
- Analgesia ยท Up to 200 mg total dose ยท IM
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Hypersensitivity to narcotic analgesics
- Patients receiving monamine oxidase inhibitors (MAOIs)
- Diarrhea caused by a toxic ingestion (until toxin is eliminated)
- Envenomations from Centruroides scorpion species, Gila monsters, or Mexican beaded lizards
- Intravenous (IV) administration
- Animals at risk from histamine release (e.g., skin allergies, asthma, mast cell tumours)
์ด์๋ฐ์
- Respiratory depression
- Histamine release
- Bronchoconstriction (dogs)
- CNS depression
- Nausea and vomiting
- Decreased intestinal peristalsis
- Mydriasis (dogs)
- Salivation (especially cats)
- Physical dependence (chronic use)
- Tachycardia with PVCs (horses)
- Profuse sweating (horses)
- Hyperpnea (horses)
- Severe hypotension (if given IV rapidly)
- Hypotension (especially if given IV)
- Tachycardia
- Bronchoconstriction
์ฝ๋ฌผ ์ํธ์์ฉ
- CNS Depressants (anesthetics, antihistamines, phenothiazines, barbiturates, tranquilizers) ยท May cause increased CNS or respiratory depression when used with meperidine.
- Diuretics ยท Opiates may decrease efficacy in CHF patients.
- Isoniazid ยท Meperidine may enhance INH adverse effects.
- Monamine Oxidase Inhibitors (MAOIs) (e.g., amitraz, selegiline) ยท Contraindicated. Can cause severe opiate overdose signs; avoid meperidine for at least 14 days after receiving MAOIs.
- Skeletal Muscle Relaxants ยท Meperidine may enhance neuromuscular blockade.
- Tricyclic Antidepressants (clomipramine, amitriptyline) ยท Meperidine may exacerbate the effects of tricyclic antidepressants.
- Warfarin ยท Opiates may potentiate anticoagulant activity.
- CNS depressants (anaesthetics, antihistamines, barbiturates, phenothiazines, tranquillizers) ยท Increased CNS or respiratory depression ยท moderate
- Monoamine oxidase inhibitors (MAOIs) ยท Serious interaction resulting in coma, convulsions, and hyperpyrexia ยท major
๋ชจ๋ํฐ๋ง
- Respiratory rate and depth
- CNS level of depression or excitation
- Blood pressure (especially with IV use)
- Analgesic activity
- Pain score
- Heart rate
- Blood pressure
- Signs of histamine release (urticaria, bronchoconstriction)
๊ณผ์ฉ๋
Overdosage may produce profound **respiratory and/or CNS depression**. Other effects can include cardiovascular collapse, hypothermia, and skeletal muscle hypotonia. * **Species Differences:** Some species (especially cats) may demonstrate CNS excitability (hyperreflexia, tremors) and seizures at doses >20 mg/kg. * **Treatment:** **Naloxone** is the agent of choice for respiratory depression. In massive overdoses, naloxone doses may need to be repeated, as its effects can diminish before subtoxic levels of meperidine are attained. Mechanical respiratory support should be considered. Pentobarbital has been suggested for CNS excitement/seizures in cats, but extreme caution is required as barbiturates and narcotics have additive respiratory depressant effects.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.